What is MediWound Ltd. (MDWD)?

MediWound Ltd. (MDWD) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of MDWD?

The current price of MDWD is $12.55. Prices are updated in real time on Stocks360.

What is MDWD's price-to-earnings (PE) ratio?

MDWD's trailing twelve-month PE ratio is -7.84, based on current price and earnings per share data available on Stocks360.

What is MDWD's market capitalization?

MDWD's market capitalization is $162,023,989.00, placing it in the small-cap tier.

MediWound Ltd. (MDWD)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$12.55

Market Cap

$162.02M

PE (TTM)

-7.84

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.14

Day Range

$12.10 – $12.60

52-wk Range

$11.80 – $19.70

Avg Volume

N/A

Volume

117.41K

MediWound Ltd. (MDWD) is a publicly traded company in the Healthcare sector. Latest price: $12.55. Market cap $162.02M. Trailing PE -7.84. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $18.27 2026-10-27 · $12.55 (-31.31%)

Earnings

Most Recent

Aug 13, 2026

EPS $-0.77 vs est. $-0.76

Missed by $0.01

Next Earnings

Nov 19, 2026

EPS estimate $-0.71

Proprietary Signals

Signal snapshot temporarily unavailable.

About MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-7.84×
P/S (TTM)	13.66×
P/B	4.54×
P/FCF (TTM)	-5.71×
EV / EBITDA	-8.80×
EV / Sales	14.10×
Earnings Yield	-12.48%
Free Cash Flow Yield	-17.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$167.22M
Revenue (TTM)	$11.86M
Net Income (TTM)	-$20.22M
Free Cash Flow (TTM)	-$27.26M
Net Debt	$5.19M
Working Capital	$24.41M
Gross Margin	15.46%
Operating Margin	-267.86%
Net Margin	-170.10%
Return on Equity	-47.24%
Return on Invested Capital	-58.55%